Patent directory · USPTO A61K / A61P
Patents matching “modified”
433 pharma patents match "modified" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 433 pharmaceutical patents matching "modified" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12129469
Modified short interfering nucleic acid (siNA) molecules and uses thereof
granted -
US 12121532
Modified antisense oligomers for exon inclusion in spinal muscular atrophy
granted -
US 12104188
Modified caspase-9 polypeptides and methods of use thereof
granted -
US 12097189
Pharmaceutical composition for modified release
granted -
US 12089575
Genetically modified mouse that expresses humanized PD1 and PD-L1 proteins
granted -
US 12084473
β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
granted -
US 12084468
Synthesis of backbone modified morpholino oligonucleotides and chimeras using phosphoramidite chemistry
granted -
US 12060497
Coatings containing polymer modified enzyme for stable self-cleaning of organic stains
granted -
US 11965190
Vectors, genetically modified bacteria, and methods of making and using
granted -
US 11945855
Recombinant polypeptides comprising modified MHC class II DRa1 domains and methods of use
granted -
US 11939604
Modified cascade ribonucleoproteins and uses thereof
granted -
US 11939591
Genetically modified MSC and therapeutic methods
granted -
US 11932695
Modified antibodies and related compounds, compositions and methods of use
granted -
US 11896599
Modified release preparations containing oxcarbazepine and derivatives thereof
granted -
US 11883431
T-cells modified to overexpress PHF19
granted -
US 11866743
Pharmaceutical formulations, methods for treating chemical warfare agent exposure, and modified biomolecules
granted -
US 11851656
Chemically modified single-stranded RNA-editing oligonucleotides
granted -
US 11851680
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)
granted -
US 11814657
Modified DNase and uses thereof
granted -
US 11807882
Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use
granted -
US 11802279
Modified L-asparaginase
granted -
US 11802292
Modified orthopoxvirus vectors
granted -
US 11793870
Live attenuated strains of foot and mouth disease modified by deoptimization and uses thereof
granted -
US 11787833
Modified cyclic dinucleoside compounds as sting modulators
granted